Company PROTEONOMIX

Equities

PROT

US74371C2089

Pharmaceuticals

Market Closed - OTC Markets 11:01:20 2023-12-21 EST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for PROTEONOMIX -.--% -.--%

Business Summary

Stromacel Inc. is a biotechnology company. The Company is a subsidiary of Proteonomix Inc. It offers technology in the field of cellular medicine to international clients. The Company intends to conduct phased human studies of its cellular materials in application to the treatment of cardiac and other diseases.

Managers

Managers TitleAgeSince
Chief Executive Officer 58 95-06-25
Director of Finance/CFO 76 12-08-01
Chief Tech/Sci/R&D Officer 55 09-01-04
Director/Board Member 73 09-12-28

Members of the board

Members of the board TitleAgeSince
Director/Board Member 73 09-12-28
Chief Executive Officer 58 95-06-25
Chief Tech/Sci/R&D Officer 55 09-01-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 3,804 0 0 100.00 %
Stock B 0 344,000 0 0
Stock C 0 50,000 0 0
Stock D 0 6 0 0
Stock E 0 200,000 0 0
Stock F 1 7,910,556 7,910,556 ( 100.00 %) 0

Shareholders

NameEquities%Valuation
200,000 - 6 000 $
NameEquities%Valuation
6 - 0 $

Company contact information

Proteonomix, Inc.

140 East Ridgewood Avenue Suite 415

07652, Paramus

+

address PROTEONOMIX(PROT)